Thermo Fisher Scientific Inc (TMO)

Add to Watchlists
Create an Alert
Quickflows
478.04 -6.81  -1.40% NYSE Apr 14, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All TMO News

News

View All Events

Events

Date Type Description
04/22/2020 08:30 EDT Earnings Calls Q1 2020 Earnings Call
04/22/2020 00:00 Earnings Results Q1 2020 Earnings Results
05/20/2020 13:00 EDT Agm 2019 Annual General Meeting
06/12/2020 None Dividends 0.22 Normal, declared May 20, 2020 and paid July 15, 2020
07/22/2020 08:30 EDT Earnings Calls Q2 2020 Earnings Call
07/22/2020 00:00 Earnings Results Q2 2020 Earnings Results
09/14/2020 None Dividends 0.22 Normal, declared July 09, 2020 and paid October 15, 2020
10/21/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/21/2020 08:30 EDT Earnings Calls Q3 2020 Earnings Call
12/14/2020 None Dividends 0.22 Normal, declared November 05, 2020 and paid January 15, 2021
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 32.22B
Total Expenses (TTM) 24.32B
Net Income (TTM) 6.375B

Balance Sheet View Statement

Total Assets (Quarterly) 69.05B
Total Liabilities (Quarterly) 34.54B
Shareholders Equity (Quarterly) 34.51B

Cash Flow Statement View Statement

Cash from Operations (TTM) 8.289B
Cash from Investing (TTM) -1.51B
Cash from Financing (TTM) 959.00M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (17%); life science solutions (38%); and lab products and services (38%).
  • URL: https://www.thermofisher.com
  • Investor Relations URL: https://ir.thermofisher.com/investors/Investor-Overview/default.aspx
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Apr. 29, 2021
  • Last Earnings Release: Feb. 01, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Mar. 15, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 478.04
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
IHI iShares US Medical Devices ETF 12.22%
XLV Health Care Select Sector SPDR® ETF 4.29%
VHT Vanguard Health Care ETF 3.36%
VGHCX Vanguard Health Care Inv 2.79%
MTUM iShares MSCI USA Momentum Factor ETF 2.76%
CAFFX American Funds AMCAP 529F1 1.78%
RWBEX American Funds Capital World Gr&Inc R2E 1.14%
CGFFX American Funds Growth Fund of Amer 529F 1.13%
IVW iShares S&P 500 Growth ETF 1.03%
VIGRX Vanguard Growth Index Investor 0.97%
VUG Vanguard Growth ETF 0.97%

Comparables

Edit
ANIX Anixa Biosciences Inc
APDN Applied DNA Sciences Inc
XGN Exagen Inc
BDSX Biodesix Inc
SHC Sotera Health Co

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.